Carregant...
Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(®) Entry assay
BACKGROUND: Fostemsavir is a prodrug of a first-in-class HIV-1 attachment inhibitor, temsavir, that binds to gp120 and blocks attachment to the host-cell CD4 receptor, preventing entry and infection of the target cell. Previous studies using a limited number of clinical isolates showed that there wa...
Guardat en:
| Publicat a: | J Antimicrob Chemother |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7879148/ https://ncbi.nlm.nih.gov/pubmed/33241285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa474 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|